RE:Very strange things----happened over the last QTR---Only two questions. From 2019 agm 1. Will we be at $2 bucks in june so that to hold pps for 90 days and enter the usa on the nasdaq as I've shown theres no awareness or coverage if u ain't on the big boards. 2. Is the GBM and NSCLC preclinical testing completed and phase 1 filings submitted. You dont have to start but getting the low cost paperwork done serves as a signal that we have an active pipeline to big money. The worst thing imo would be to have the morning star pps and go to an agm with management sputtering utter trash statements to shareholders. I would much prefer the natural 5-10x and a pp done to fund the 2nd indication. At least we would have a base price at $1.25 - $2 w warrants at a decent level. This isnt 2014 risk its fully derisked science. This ain't photofrin with no way to measure light dosing using the wrong red light and still getting a cr rate. Were using a fully technically refined and dose optimized via computer calculation for light and bladder shape truly 21st tech. Ffs
Impalaman wrote: Their will be NO--news releases--only quarterly-----after the FDA puts us on hold----no new patients being treated for almost a month---there most likely are 4-5 more treated-----now we cannot let our investors get any good news before march 07th can we---dont want the price to get over 0.54----hheeyyy---there's a lot of news releases coming in the second week of march---first a NR on ---probably 4-5 more patients treated----# 5-6 --2 yr cancer free---and then FDA approvaI by the end of march(the big kahona)--then more big 90 and 180 day updates in april before important meetings in may---hopefully more patients being treated in the US--in the 3-QTR.---should be a great 2020.